COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of coronavirus disease 2019 (COVID-19). It is known as a respiratory virus, but SARS-CoV-2 appears equally, or even more, infectious for the olfactory epithelium (OE) than for the respiratory epithelium in the nas...
Guardado en:
Autores principales: | Fengyi Liang, De Yun Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b8222442ca7041e5a1ff7696e63f9dca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anosmia y enfermedad por Coronavirus 2019 (COVID-19): ¿Qué debemos saber?
por: Sepúlveda C,Valeria, et al.
Publicado: (2020) -
Use of B‐complex vitamins and olfactory training for treating COVID‐19–related anosmia
por: Yethindra Vityala, et al.
Publicado: (2021) -
Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD?
por: Sarah A. Imam, MD, et al.
Publicado: (2020) -
Anosmia, trigeminal nerve dysfunction, and COVID-19: A personal account
por: Hideaki Moteki
Publicado: (2021) -
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)